|
1
|
Mohammadpour H, Pourfathollah AA, Zarif MN
and Tahoori MT: TNF-α modulates the immunosuppressive effects of
MSCs on dendritic cells and T cells. Int Immunopharmacol.
28:1009–1017. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Romano M, Fanelli G, Tan N, Nova-Lamperti
E, McGregor R, Lechler RI, Lombardi G and Scottà C: Expanded
regulatory T cells induce alternatively activated monocytes with a
reduced capacity to expand T helper-17 cells. Front Immunol.
9:16252018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Özdemir AT, Özgül Özdemir RB, Kırmaz C,
Sarıboyacı AE, Ünal Halbutoğlları ZS, Özel C and Karaöz E: The
paracrine immunomodulatory interactions between the human dental
pulp derived mesenchymal stem cells and CD4 T cell subsets. Cell
Immunol. 310:108–115. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Heidt S, Segundo DS, Chadha R and Wood KJ:
The impact of Th17 cells on transplant rejection and the induction
of tolerance. Curr Opin Organ Transplant. 15:456–461. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sun Z, Li T, Wen H, Wang H, Ji W and Ma W:
Immunological effect induced by mesenchymal stem cells in a rat
liver transplantation model. Exp Ther Med. 10:401–406. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gharibi T, Ahmadi M, Seyfizadeh N,
Jadidi-Niaragh F and Yousefi M: Immunomodulatory characteristics of
mesenchymal stem cells and their role in the treatment of multiple
sclerosis. Cell Immunol. 293:113–121. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim N and Cho SG: Overcoming
immunoregulatory plasticity of mesenchymal stem cells for
accelerated clinical applications. Int J Hematol. 103:129–137.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhou Y, Yang X, Zhang H and Jiang J: The
roles of T helper type 17/regulatory T cells in acute rejection
after liver transplantation in rats. Transplantation. 99:1126–1131.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu X, Ren S, Qu X, Ge C, Cheng K and Zhao
RC: Mesenchymal stem cells inhibit Th17 cells differentiation via
IFN-ү-mediated SOCS3 activation. Immunol Res. 61:219–229. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tang J, Yang R, Lv L, Yao A, Pu L, Yin A,
Li X, Yu Y, Nyberg SL and Wang X: Transforming growth
factor-β-expressing mesenchymal stem cells induce local tolerance
in a rat liver transplantation model of acute rejection. Stem
Cells. 34:2681–2692. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rozenberg A, Rezk A, Boivin MN, Darlington
PJ, Nyirenda M, Li R, Jalili F, Winer R, Artsy EA, Uccelli A, et
al: Human mesenchymal stem cells impact Th17 and Th1 responses
through a prostaglandin E2 and myeloid-dependent mechanism. Stem
Cells Transl Med. 5:1506–1514. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rashedi I, Gómez-Aristizábal A, Wang XH,
Viswanathan S and Keating A: TLR3 or TLR4 activation enhances
mesenchymal stromal cell-mediated treg induction via notch
signaling. Stem Cells. 35:265–275. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sioud M, Mobergslien A, Boudabous A and
Fløisand Y: Evidence for the involvement of galectin-3 in
mesenchymal stem cell suppression of allogeneic T-cell
proliferation. Scand. J Immunol. 71:267–274. 2010.
|
|
14
|
Chen W, Huang Y, Han J, Yu L, Li Y, Lu Z,
Li H, Liu Z, Shi C, Duan F and Xiao Y: Immunomodulatory effects of
mesenchymal stromal cells-derived exosome. Immunol Res. 64:831–840.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Qu X, Liu X, Cheng K, Yang R and Zhao RC:
Mesenchymal stem cells inhibit Th17 cell differentiation by IL-10
secretion. Exp Hematol. 40:761–770. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu G, Wang L, Chen W, Xue F, Bai X, Liang
L, Shen X, Zhang M, Xia D and Liang T: Rapamycin and tacrolimus
differentially modulate acute graft-versus-host disease in rats
after liver transplantation. Liver Transpl. 16:357–363. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hajkova M, Hermankova B, Javorkova E,
Bohacova P, Zajicova A, Holan V and Krulova M: Mesenchymal stem
cells attenuate the adverse effects of immunosuppressive drugs on
distinct T cell subopulations. Stem Cell Rev Rep. 13:104–115. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang JX, Zhang N, Wang HW, Gao P, Yang QP
and Wen QP: CXCR4 receptor overexpression in mesenchymal stem cells
facilitates treatment of acute lung injury in rats. J Biol Chem.
290:1994–2006. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tang RJ, Shen SN, Zhao XY, Nie YZ, Xu YJ,
Ren J, Lv MM, Hou YY and Wang TT: Mesenchymal stem cells-regulated
Treg cells suppress colitis-associated colorectal cancer. Stem Cell
Res Ther. 6:712015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Engela AU, Hoogduijn MJ, Boer K, Litjens
NH, Betjes MG, Weimar W and Baan CC: Human adipose-tissue derived
mesenchymal stem cells induce functional de-novo regulatory T cells
with methylated FOXP3 gene DNA. Clin Exp Immunol. 173:343–354.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Laurence A, Tato CM, Davidson TS, Kanno Y,
Chen Z, Yao Z, Blank RB, Meylan F, Siegel R, Hennighausen L, et al:
Interleukin-2 signaling via STAT5 constrains T helper 17 cell
generation. Immunity. 26:371–381. 2007. View Article : Google Scholar : PubMed/NCBI
|
